X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Many consumers still face confusion around health insurance coverage

By Rebecca Davison  |    May 25, 2016
Consumers need to be engaged and empowered when making decisions about their health coverage. Two recent studies suggest more can be done to help consumers sort through their health insurance...   Read More

A state-by-state look at coverage and access hurdles in 2016 exchange plans

By Rebecca Davison  |    May 6, 2016
We frequently talk about access barriers patients with health insurance exchange plans face, including two recent studies from Avalere Health and Harvard University Center for Health Law and...   Read More

New Avalere study: Health plan formularies continue to suggest bias against individuals with certain health conditions

By Karyn Schwartz  |    April 19, 2016
Despite warnings from the Centers for Medicare & Medicaid Services (CMS) that requiring high cost sharing for all or most medications to treat a condition may be discriminatory, new data from...   Read More

New report confirms competitive market works; Net prices for medicines increased just 2.8 percent in 2015

By Holly Campbell  |    April 14, 2016
Despite misleading claims made about spending on new innovative treatments and cures, another report confirms how the competitive biopharmaceutical market works to control costs. Net prices for...   Read More

New Study: Patient cost sharing rising as plans push more costs to patients through deductibles, coinsurance

By Karyn Schwartz  |    April 13, 2016
New data show changes in how insurers structure health insurance benefits have made out-of-pocket costs harder for patients to budget for or predict. A Kaiser Family Foundation analysis released...   Read More

New research: Insurance plan structure can have discriminatory effect

By Karyn Schwartz  |    March 31, 2016
New research from the Harvard University Center for Health Law and Policy Innovation (CHLPI) is another piece of evidence showing how health insurance plan design may be trying to discourage...   Read More

When coverage does not equal access to care

By Karyn Schwartz  |    February 19, 2016
Building on recent stories about the challenges even those with insurance are facing, new data show some consumers have no choice but to pay up to thousands of dollars out of pocket before their...   Read More

Do you know how insurance covers your medicines?

By Allyson Funk  |    January 14, 2016
You’ve seen our check lists of questions to ask about your insurance coverage and how to make sure your medicines are covered, but do you know how (and if) your insurance plan covers your...   Read More

Burden on Patients: 5 Questions on access to multiple sclerosis medicines in health exchange plans

By Allyson Funk  |    December 4, 2015
Patients, especially those suffering from chronic conditions, deserve access to the medicines they need to live longer, healthier lives. Today, PhRMA released a new fact sheet on access to...   Read More

Who is pushing for price controls? The answer may surprise you

By Priscilla VanderVeer  |    August 24, 2015
Progress in medical innovation over the past few years has been nothing short of remarkable. A once incurable disease – hepatitis C – now has cure rates above 90 percent. Patients previously...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates